Cargando…
One Size Does Not Fit All: The Case for Translational Medicine
Therapy for inflammatory bowel diseases (IBD) has developed during recent years. Despite the availability of new therapeutic modalities, overall therapy success remains modest, and complete remission is usually achieved and maintained in approximately 30% of patients only. This observation can be ex...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rambam Health Care Campus
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474761/ https://www.ncbi.nlm.nih.gov/pubmed/30860477 http://dx.doi.org/10.5041/RMMJ.10364 |